Peter C. Frommelt

Peter C. Frommelt

Auto-generated profile, based on publicly available information

Peter C. Frommelt

Medical College of Wisconsin, Children’s Hospital of Wisconsin

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 May 2012 in Circulation
Verified
Journal Article
Closed access
PDF file
PFPeter C. Frommelt
Peter C. Frommelt
LGLin T. Guey
Lin T. Guey
LML. LuAnn Minich
L. LuAnn Minich
MBMajeed Bhat
Majeed Bhat
TBTim J. Bradley
Tim J. Bradley
MCMeryl S. Cohen
Meryl S. Cohen
Background—: The Pediatric Heart Network trial comparing outcomes in 549 infants with single right ventricle undergoing a Norwood procedure randomized to modified Blalock-Taussig shunt or right ventricle–pulmonary artery shunt (RVPAS) found better 1-year transplant-free survival in those who received RVPAS. We sought to compare the impact of shunt type on echocardiographic indices of cardiac size and function up to 14 months of age. Methods and Results—: A core laboratory measured indices of cardiac size and function from protocol exams: early after Norwood procedure (age 22.5±13.4 days), before stage II procedure (age 4.8±1.8 months), and at 14 months (age 14.3±1.2 months). Mean right ventricular ejection fraction was <50% at all intervals for both groups and was higher in the RVPAS group after Norwood procedure (49±7% versus 44±8%; P <0.001) but was similar by 14 months. Tricuspid and neoaortic regurgitation, diastolic function, and pulmonary artery and arch dimensions were similar in the 2 groups at all intervals. Neoaortic annulus area (4.2±1.2 versus 4.9±1.2 cm 2 /m 2 ), systolic ejection times (214.0±29.4 versus 231.3±28.6 ms), neoaortic flow (6.2±2.4 versus 9.4±3.4 L/min per square meter), and peak arch velocity (1.9±0.7 versus 2.2±0.7 m/s) were lower at both interstage examinations in the RVPAS compared with the modified Blalock-Taussig shunt group ( P <0.001 for all), but all were similar at 14 months. Conclusions—: Indices of cardiac size and function after the Norwood procedure are similar for modified Blalock-Taussig shunt and RVPAS by 14 months of age. Interstage differences between shunt types can likely be explained by the physiology created when the shunts are in place rather than by intrinsic differences in cardiac function. Clinical Trial Registration—: URL: http://www.clinicaltrials.gov . Unique identifier: NCT00115934.

3 November 2014 in JACC
Verified
Journal Article
Closed access
PDF file
PFPeter C. Frommelt
Peter C. Frommelt
EGEric Gerstenberger
Eric Gerstenberger
JCJames F. Cnota
James F. Cnota
MCMeryl S. Cohen
Meryl S. Cohen
JGJessica Gorentz
Jessica Gorentz
JNJane W. Newburger
Jane W. Newburger

24 October 2023 in Circulation
Verified
Journal Article
Open access
CGCaren S. Goldberg
Caren S. Goldberg
FTFelicia Trachtenberg
Felicia Trachtenberg
JGJames W. Gaynor
James W. Gaynor
WMWilliam T. Mahle
William T. Mahle
CRChitra Ravishankar
Chitra Ravishankar
OIon behalf of the Pediatric Heart Network Investigators
on behalf of the Pediatric Heart Network Investigators
OBJECTIVE: In the SVR trial (Single Ventricle Reconstruction), newborns with hypoplastic left heart syndrome were randomly assigned to receive a modified Blalock-Taussig-Thomas shunt (mBTTS) or a right ventricle-to-pulmonary artery shunt (RVPAS) at Norwood operation. Transplant-free survival was superior in the RVPAS group at 1 year, but no longer differed by treatment group at 6 years; both treatment groups had accumulated important morbidities. In the third follow-up of this cohort (SVRIII [Long-Term Outcomes of Children With Hypoplastic Left Heart Syndrome and the Impact of Norwood Shunt Type]), we measured longitudinal outcomes and their risk factors through 12 years of age. METHODS: Annual medical history was collected through record review and telephone interviews. Cardiac magnetic resonance imaging (CMR), echocardiogram, and cycle ergometry cardiopulmonary exercise tests were performed at 10 through 14 years of age among participants with Fontan physiology. Differences in transplant-free survival and complication rates (eg, arrhythmias or protein-losing enteropathy) were identified through 12 years of age. The primary study outcome was right ventricular ejection fraction (RVEF) by CMR, and primary analyses were according to shunt type received. Multivariable linear and Cox regression models were created for RVEF by CMR and post-Fontan transplant-free survival. RESULTS: Among 549 participants enrolled in SVR, 237 of 313 (76%; 60.7% male) transplant-free survivors (mBTTS, 105 of 147; RVPAS, 129 of 161; both, 3 of 5) participated in SVRIII. RVEF by CMR was similar in the shunt groups (RVPAS, 51±9.6 [n=90], and mBTTS, 52±7.4 [n=75]; P =0.43). The RVPAS and mBTTS groups did not differ in transplant-free survival by 12 years of age (163 of 277 [59%] versus 144 of 267 [54%], respectively; P =0.11), percentage predicted peak V o 2 for age and sex (74±18% [n=91] versus 72±18% [n=84]; P =0.71), or percentage predicted work rate for size and sex (65±20% versus 64±19%; P =0.65). The RVPAS versus mBTTS group had a higher cumulative incidence of protein-losing enteropathy (5% versus 2%; P =0.04) and of catheter interventions (14 versus 10 per 100 patient-years; P =0.01), but had similar rates of other complications. CONCLUSIONS: By 12 years after the Norwood operation, shunt type has minimal association with RVEF, peak V o 2 , complication rates, and transplant-free survival. RVEF is preserved among the subgroup of survivors who underwent CMR assessment. Low transplant-free survival, poor exercise performance, and accruing morbidities highlight the need for innovative strategies to improve long-term outcomes in patients with hypoplastic left heart syndrome. REGISTRATION: URL: https://www.clinicaltrials.gov ; Unique identifier: NCT0245531.

1 April 2018 in The Journal of Thoracic and Cardiovascular Surgery
Verified
Journal Article
Closed access
SSShagun Sachdeva
Shagun Sachdeva
MFMichele A. Frommelt
Michele A. Frommelt
MMMichael E. Mitchell
Michael E. Mitchell
JTJames S. Tweddell
James S. Tweddell
PFPeter C. Frommelt
Peter C. Frommelt

12 November 2007 in Echocardiography
Verified
Journal Article
Closed access
PDF file
SKShelby Kutty
Shelby Kutty
SDSara L. Deatsman
Sara L. Deatsman
MNMelodee L. Nugent
Melodee L. Nugent
DRDavid Russell
David Russell
PFPeter C. Frommelt
Peter C. Frommelt

9 September 2008 in Pediatric Cardiology
Verified
Journal Article
Closed access
PDF file
APAmy L. Peterson
Amy L. Peterson
SDSara Deatsman
Sara Deatsman
MFMichele A. Frommelt
Michele A. Frommelt
KMKathy Mussatto
Kathy Mussatto
PFPeter C. Frommelt
Peter C. Frommelt